为什么VA-ECMO不应该在AMI-心脏性休克中常规使用
Holger Thiele1, Steffen Desch1, Anne Freund1
1Heart Center Leipzig at Leipzig University, Department of Internal Medicine/Cardiology, Leipzig, Germany; Leipzig Heart Science, Leipzig, Germany.
静脉外体膜氧化 (VA-ECMO) 对心脏性休克患者的死亡率没有好处. 目前的证据表明并发症率增加,因此需要对这种先进疗法进行仔细的患者选择.
科学领域:
- 心脏病学 心脏病学
- 临界护理医学 临界护理医学
- 心血管外科心血管外科
背景情况:
- 心脏性休克是一种危及生命的疾病,需要先进的血液动力学支持.
- 静脉外体膜氧化 (VA-ECMO) 是一种已建立的机械循环支持装置.
研究的目的:
- 审查目前关于VA-ECMO在心脏性休克中疗效和安全性的证据.
- 确定可能从VA-ECMO治疗中受益的潜在患者子组.
主要方法:
- 随机对照试验 (RCT) 的系统审查,评估VA-ECMO对心脏性休克的评估.
- 分析安全性和疗效数据,包括死亡率和并发症率.
主要成果:
- 审查了四个RCT,没有一个证明VA-ECMO在心脏性休克中对死亡率有好处.
- 使用VA-ECMO与并发症率的增加有关.
- 证据表明益处有限,需要仔细考虑患者选择.
结论:
- 目前的证据不支持VA-ECMO在所有心脏性休克患者的常规使用.
- 需要进一步的研究来确定可能受益于VA-ECMO的特定患者子组.
- 仔细的患者选择和风险益处评估对于VA-ECMO的实施至关重要.
更多相关视频
03:40Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
Published on: January 17, 2025
07:41Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
Published on: July 20, 2022
相关概念视频
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Heart Failure Drugs: Inotropic Agents
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Assessment of the Cardiovascular System IV: Auscultation
Normal Heart Sounds
S1 (First Heart Sound)-
S1 is made by the closure of the mitral and tricuspid valves (atrioventricular valves), marking the beginning of systole.
S2 (Second Heart Sound)-
S2 is made by the closure of the aortic and pulmonic valves (semilunar valves), marking the end of the systole.
